Industry watchers responded mostly positively to the commissioner’s new voucher program, but worries remain over staffing cuts at the agency.

Oral presentation on study demonstrating the ability of sotagliflozin to reduce the risk of hypoglycemic events regardless of kidney function in people with type 1 diabetesTHE WOODLANDS, Texas, June ...

InvestingPro’s Fair Value analysis has once again demonstrated its effectiveness in identifying undervalued opportunities, with Lexicon Pharmaceuticals (NASDAQ:LXRX) delivering a remarkable 67% return ...

InvestingPro’s Fair Value analysis has once again demonstrated its effectiveness in identifying undervalued opportunities, with Lexicon Pharmaceuticals (NASDAQ:LXRX) delivering a remarkable 67% ...

In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other Friday’s best-performing stocks. Recursion Pharmaceuticals grew its share ...